Authors
Latest:
ARVO 2025: Retina extracellular vesicles in diabetic retinopathyAt ARVO 2025, in Salt Lake City, Utah, Emma Lessieur-Contreras, MD, PhD, talked about her poster on retina extracellular vesicles, and the role that they play on diabetic retinopathy.
Latest:
Q&A: Malvina Eydelman, MD, on leading CCOI and catalyzing global ophthalmic innovationShifting from a regulatory role to driving innovation directly, Eydelman discusses how the Collaborative Community on Ophthalmic Innovation is reshaping the field, streamlining outdated processes, and advancing patient-centered solutions worldwide.
Latest:
Presbyopia treatment success begins with patient-centered carePersonalizing treatment options and setting realistic expectations are crucial.
Latest:
Envision Summit 2025: New developments in glaucoma treatment and tailoring them to the patientAt the Envision Summit 2025 in San Juan, Puerto Rico, Rachel Simpson, MD, talked about new developments in glaucoma treatment and really how to tailor glaucoma treatment to the patient.
Latest:
Pass-through provides vehicle to drive innovationAs more novel ophthalmic drugs and devices become available under the CMS “pass-through”designation, practices should be proactive in embracing these products.
Latest:
The Residency Report: Study provides new insights into USH2A target end pointsResearchers evaluate key measures for tracking disease progression in Usher syndrome type 2–related retinal degeneration
Latest:
Children’s mental health and the impact of vision impairmentTwo studies conducted in collaboration with Orbis International explore how providing free glasses to children improves their ability to learn in school and that addressing visual impairment in children can alleviate depression and anxiety.
Latest:
Payment models for imaging: Procedures not covered by insurance policiesTips to help eye care providers navigate the maze of insurance issues.
Latest:
Posterior corneal elevation: Is there a role for premium IOLs?Trifocal IOLs can, if implanted with caution, be suitable for patients with keratoconus.
Latest:
Case 3: Treating nAMD in the Presence of Geographic AtrophyRetina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Latest:
Cryopreserved amniotic membrane an option treatment of mechanical dry eyeReservoir restoration can re establish the normal anatomy and function of the conjunctiva.
Latest:
Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopiaResearch explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.
Latest:
New molecule for allergic conjunctivitis makes debutFirst new therapy in nearly a decade offers another option for physicians, patients
Latest:
Good nutrition optimizes ocular surface in premium cataract patientsImprovements gained prior to surgery can result in positive outcomes.
Latest:
Froin syndrome: Eyes are the window to the spinePapilledema with back pain suggests spine lesion.
Latest:
Blog: In honor of those who lift usIt’s been a minute, as the Baltimorean’s say, but I still remember my first day of residency. I knew next to nothing about ophthalmology but showed up smiling and eager to learn. I felt incredibly fortunate to be training at such a prestigious institution. I was awed by the distinguished faculty, and my co-residents couldn’t be any more impressive. In short, I wasn’t sure I belonged.
Latest:
More to keratoconus than meets the cornea: Be sure to flip the lidsEqually important is that any symptoms of ocular allergies should be addressed to reduce the frequency of eye rubbing.
Latest:
Envision Summit 2025: Deep learning models of neovascular AMDAt the Envision Summit 2025 in San Juan, Puerto Rico, retina program chairs Geeta Lalwani, MD, and Majda Hadziahmetovic, MD, discussed Hadziahmetovic's presentation on deep learning models of neovascular AMD as well as their time at the conference.
Latest:
Case 3: Treating nAMD in the Presence of Geographic AtrophyRetina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Tackling the challenge of noninfectious uveitisChronic cases can be difficult for retinal specialists, but treatment is satisfying.
Latest:
Navigating the COVID-19 pandemic with ophthalmic patients in the hospital settingNew operating procedures ensure eye clinics can operate safely amid virus.
Latest:
ARVO 2025: Sex-specific biomarkers for Parkinson's disease in retinal microvascular imagingAt the ARVO 2025 meeting in Salt Lake City, Utah, Cameron Cummings presented a poster on how retinal microvascular imaging metrics may show sex-specific biomarkers for Parkinson's disease.
Latest:
The Residency Report: Study provides new insights into USH2A target end pointsResearchers evaluate key measures for tracking disease progression in Usher syndrome type 2–related retinal degeneration
Latest:
BLOG: The PTVT Trial and Clinical ApplicationsJoseph F. Panarelli MD, Steven J. Gedde, MD, and Vikram Paranjpe MD, MPH discuss the Primary Tube Versus Trabeculectomy (PTVT) study.
Latest:
The Impressions and Takeaways from Patient Case No. 2An expert underscores the importance of a comprehensive dry eye examination and offers insights on distinguishing it from neurotrophic keratitis.
